Registered Nurse

Healogics competitors: why more hospitals are choosing Wound Care Advantage. Mike comer. Wound Care Advantage (WCA) is the leading alternative to Healogics, Restorix, and other traditional wound care management companies. Unlike a management company, WCA is a support partner. Your hospital keeps ownership of its staff, equipment, data, and revenue, while WCA provides the expertise, technology, and daily coaching to outperform the management-company model. For over 24 years, hospital executives nationwide have turned to WCA to cut costs and improve clinical and financial outcomes in their wound centers. The three alternatives hospitals actually have. When a hospital starts searching for a Healogics alternative, most assume the only path forward is one of the other Healogics competitors in the management-company space. In reality, there are three primary options: | Option | What It Is | Best For | | Wound Care Advantage | Support partner model | Hospitals that want to own their wound care program with expert backing | | Hospital-Operated | Hospital runs the program alone | Hospitals with deep internal expertise and resources to keep up with regulatory change | | Renegotiate Current Vendor | Stay in the management-company model | Hospitals where the existing partnership still delivers value | Most hospitals choose the support partner model because it's the only option that preserves clinical control and program margin while delivering the regulatory, billing, and operational expertise a modern wound center demands. Why hospitals look for an alternative to Healogics. The frustration we hear from hospital C-suites isn't about Healogics specifically. Healogics is an exceptional company that has helped stand up hundreds of Advanced Wound Care programs across the country and, by extension, helped heal hundreds of thousands of patients. The frustration is often with the management model itself, a traditional approach that fails to recognize that no two hospitals operate the same way. Four issues drive most conversations: * Intangible Costs. The management fee is the visible number. The hidden costs - staff loyalty, filtered reporting, and denial risk - add up to more. * Transparency. Your CFO usually can't pull real-time wound-center performance data without asking the management company first. That's outsourced visibility. * Control. The staff in your wound center work for the management company, not your hospital. Training, career development, and loyalty all point elsewhere. * Conflict of interest. If your management company operates hundreds of centers, the odds are meaningful they may also run one at a competing hospital in your market - building referral relationships for your competitor while collecting your management fee. The equipment question (and why it's not the barrier you think). The most common reason hospitals stay longer than they should is equipment owned by the company, specifically hyperbaric chambers. The implicit threat that looms over the thought of transitioning to an alternative option is: leave, and you lose your HBOT program. That is not the reality, the reality comes down to three things: * The chambers have almost certainly been paid for several times over through years of management fees. * New chambers can be leased or purchased independently. A facility running 30 HBOT treatments per month can pay off two chambers in under a year - after that, every treatment flows to the hospital's bottom line. * A management company transition is an opportunity to evaluate your hyperbaric equipment options, especially when the current manufacturer is affiliated with the outgoing management company. WCA helps with the entire chamber transition: introductions to manufacturers, lease vs. purchase analysis, and installation. No disruption to patient care. What the WCA Support Model looks like. | / | Management Company Model | WCA Support Model | | Wound Center Staff | Employed by the management company | Employed by your hospital | | Hyperbaric Chambers | Owned by the management company | Owned by your hospital | | Performance Data | Filtered, on a pre-determined timeline presented by company | Real-time via the Luvo platform | | Denial & Collection Risk | Minimal denial risk prevention, Hospital absorbs it alone | WCA helps prevent audits and recover lost revenue | | Conflict of Interest | Have ran competing centers in current client markets | WCA supports your market, keeping your community's patients your own | | What You Pay For | A management fee plus hidden costs | Customized support, subject matter expertise, and technology platform | The transition is less disruptive than you think. Hospitals transition out of management contracts and into the WCA support model routinely. We have done it more than 100 times in the last ten years alone. Most see financial impact within the first year: revenue cycle improvements recover money that was being written off, compliance infrastructure strengthens, and volume grows because your team is now building referrals in your community. If some current staff belong to the management company and don't stay through the transition, WCA helps you hire and train replacements before patient care is affected. Before you decide. This isn't really about leaving your management company. It's about your hospital, your wound center, your patients, and your mission. If the current relationship serves those priorities, keep it. If it doesn't, and you'll know in your gut, the next question is what comes next. Talk to WCA to see what your wound center looks like with and without a management company, and what it could become with the right partner. Frequently asked questions. What is the best alternative to Healogics? Wound Care Advantage (WCA) is the leading alternative to Healogics for hospitals that want to keep ownership of their wound care program. WCA is a support partner, not a management company. WCA has supported more than 100+ hospital-based wound centers over 24 years. Who are Healogics' competitors? Healogics competitors in the traditional management-company space include Restorix Health and other regional wound care operators. The leading non-management alternative to Healogics is Wound Care Advantage, which operates under a support-partner model rather than taking over the wound center. What's the difference between a wound care management company and a support partner? A management company takes over the wound center - staffing it with their employees, providing equipment they own, and controlling reporting. A support partner like WCA works alongside the hospital's existing team, leaving ownership of staff, equipment, data, and revenue with the hospital while providing expertise, technology, and coaching. Do we have to replace our staff when we leave a management company? It depends on the contract. Some wound-center employees work for the management company and will leave with them. WCA identifies this early, helps hire and train replacements, and supports continuity. In most cases, the hospital-employed staff already on your team stay through the transition. What happens to our hyperbaric chambers if we leave? In most contracts the chambers belong to the management company and leave with them. WCA helps source replacement chambers, makes introductions to manufacturers, models lease vs. purchase economics, and manages installation. A facility running 30 HBOT treatments per month can typically pay off two new chambers in under a year. Will leaving a management company disrupt patient care? Not when the transition is structured. WCA has executed this transition and has a standard process that protects continuity of staffing, scheduling, EMR, and HBOT availability throughout. What is a VOICE Assessment? A free evaluation WCA conducts on a wound center across five areas - Volume, Outcomes, Income, Compliance, and Employee engagement. It gives hospital leadership a clear picture of where the program stands today, what's performing, what's at risk, and where the revenue gaps are. No cost, no obligation. How long has Wound Care Advantage been operating? 24 years. WCA was founded on the mission that every community deserves access to advanced wound care and hyperbaric medicine, and partners with hospital networks nationwide. About Wound Care Advantage Wound Care Advantage (WCA) is the nation's leading wound center consultancy and the leading alternative to traditional management companies including Healogics and Restorix. WCA helps hospital networks optimize clinical outcomes, compliance, and profitability across their wound care and hyperbaric medicine programs. Founded 24 years ago, WCA has consulted for more than 200 hospital-based wound centers.

Healogics names John P. Landino as Chief Development Officer. * March 10, 2026 Healogics recently appointed John P. Landino as its new Chief Development Officer. Specifically, Landino will spearhead growth strategies for the nation's leading advanced wound care provider. He brings nearly 20 years of specialized experience in business development. Previously, he held senior leadership roles at Fresenius Medical Care and Tenet Healthcare. His background includes building vital partnerships with hospital executives and healthcare leaders. Furthermore, John P. Landino will focus on creating new business opportunities to expand the company's mission. This appointment arrives as Healogics celebrates 30 Years of Healing. Consequently, the organization aims to further strengthen its commitment to clinical innovation. Meanwhile, his leadership will support rapid and sustainable growth across the network. Additionally, he will oversee initiatives to enhance physician engagement nationwide. "John's extensive experience in healthcare development and his innovative approach make him an ideal leader for our growth initiatives," said Pamela Mandel, Chairman and Chief Executive Officer of Healogics. "We are thrilled to welcome him to our executive team, and we look forward to working together as we continue to strengthen our partnerships and expand access to advanced wound care in more communities." Notably, Healogics remains the top provider of hyperbaric oxygen therapy services. Therefore, Landino's role is crucial for shaping the future of the healing process. Moreover, his expertise in forging strategic alliances will benefit various healthcare sectors. "I could not be more excited to be part of Healogics, the nation's leading wound care organization," said John. "The company's track record of innovation and impact makes this an incredible opportunity. I look forward to working with our team and partners to expand our reach and help shape the future of healing for communities nationwide." For more stories on technology leaders shaping the future of enterprise solutions, visit its CXO Insiders. CXO Insiders. * March 10, 2026 * March 9, 2026

Healogics, the nation's leading provider of advanced wound care and hyperbaric oxygen therapy services, has appointed John P. Landino as chief development officer. Landino brings nearly 20 years of business development experience, having held key leadership roles at Fresenius Medical Care North America and Tenet Healthcare. In his new role, Landino will lead Healogics' growth strategy, expanding partnerships and business opportunities. The appointment coincides with the company's 30th anniversary. Jacksonville, Florida-based Healogics partners with hospitals and health systems nationwide to deliver specialised care for patients with chronic wounds, supported by the world's largest wound care outcomes database.